Page last updated: 2024-10-30

mesalamine and Breast Cancer

mesalamine has been researched along with Breast Cancer in 4 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
" One comparing two different dosing regimens for the maintenance of remission in people with ulcerative colitis (CODA), and the other comparing an orally administered treatment to an intravenously administered treatment in preventing skeletal-related events in patients with bone metastases from breast cancer (ZICE)."1.46The use of randomisation-based efficacy estimators in non-inferiority trials. ( Barrett-Lee, P; Casbard, A; Farewell, D; Gillespie, D; Hawthorne, AB; Hood, K; Hurt, C; Murray, N; Probert, C; Stenson, R, 2017)
"Azathioprine (AZA) treatment in transplant or autoimmune patients and subsequent appearance squamous cell carcinomas at various sites, particularly skin and cervix, has shown a close relationship."1.38[A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine]. ( Cho, JY; Heo, SW; Ju, DU; Kim, EJ; Kim, EY; Oh, HK; Park, KC; Ryu, JI, 2012)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Moreno Moraleda, I1
Lázaro Sáez, M1
Diéguez Castillo, C1
Hernández Martínez, Á1
Gillespie, D1
Farewell, D1
Barrett-Lee, P1
Casbard, A1
Hawthorne, AB1
Hurt, C1
Murray, N1
Probert, C1
Stenson, R1
Hood, K1
Park, KC1
Ju, DU1
Heo, SW1
Ryu, JI1
Cho, JY1
Kim, EJ1
Oh, HK1
Kim, EY1
Schwetz, BA1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Zoledronate Versus Ibandronate Comparative Evaluation: A Randomized Phase III, Open-Label, Multicenter, Parallel Group Clinical Trial to Evaluate and Compare the Efficacy, Safety Profile and Tolerability of Oral Ibandronate Versus Intravenous Zoledronate [NCT00326820]Phase 31,404 participants (Actual)Interventional2006-01-31Active, not recruiting
A Randomized, Single-Blind Study to Assess Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily Versus Divided Doses 3 Times Daily for 12 Months in Maintenance of Remission of Ulcerative Colitis.[NCT00708656]Phase 3213 participants (Actual)Interventional2006-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for mesalamine and Breast Cancer

ArticleYear
Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
    Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:2

    Topics: Adenocarcinoma; Adult; Age of Onset; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Colit

2021
The use of randomisation-based efficacy estimators in non-inferiority trials.
    Trials, 2017, 03-09, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Anti-Inflammatory Agents; Bone Density Conservati

2017
The use of randomisation-based efficacy estimators in non-inferiority trials.
    Trials, 2017, 03-09, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Anti-Inflammatory Agents; Bone Density Conservati

2017
The use of randomisation-based efficacy estimators in non-inferiority trials.
    Trials, 2017, 03-09, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Anti-Inflammatory Agents; Bone Density Conservati

2017
The use of randomisation-based efficacy estimators in non-inferiority trials.
    Trials, 2017, 03-09, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Anti-Inflammatory Agents; Bone Density Conservati

2017
[A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 60, Issue:6

    Topics: Adult; Azathioprine; Breast Neoplasms; Carcinoma, Squamous Cell; Colonoscopy; Combined Modality Ther

2012
From the Food and Drug Administration.
    JAMA, 2001, Mar-07, Volume: 285, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as

2001